StockData
BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp. (BCTX) stock

BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30
$3.28−0.23 (-6.55%)

Close on Nov 18, 2026Market cap $28.64MP/E –Yield –

BriaCell Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

BriaCell Therapeutics's shares outstanding was 8M at Jul 31, 2026. For fiscal 2026 it was 5M, up 1084.3% from the year before. The highest annual figure on record is 5M in fiscal 2026.

Annual shares outstanding

PeriodPeriod endValueChange
FY2026Jul 31, 20265M+1084.3%
FY2025Jul 31, 20250M+285.7%
FY2024Jul 31, 20240M+5.3%
FY2023Jul 31, 20230M+0.8%
FY2022Jul 31, 20220M+242.8%
FY2021Jul 31, 20210M+533.1%
FY2020Jul 31, 20200M+23.2%
FY2019Aug 1, 20190M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jul 31, 20268M+2102.0%
Q3 FY2026CQ1 2026Apr 30, 20267M+2585.8%
Q2 FY2026CQ4 2025Jan 31, 20263M+1477.8%
Q1 FY2026CQ3 2025Oct 31, 20252M+1481.0%
Q3 FY2025CQ1 2025Apr 30, 20250M+250.1%
Q2 FY2025CQ4 2024Jan 31, 20250M+153.4%
Q1 FY2025CQ3 2024Oct 31, 20240M+59.8%
Q4 FY2024CQ2 2024Jul 31, 20240M+12.2%
Q3 FY2024CQ1 2024Apr 30, 20240M+3.0%
Q2 FY2024CQ4 2023Jan 31, 20240M+3.0%
Q1 FY2024CQ3 2023Oct 31, 20230M+7.5%
Q4 FY2023CQ2 2023Jul 31, 20230M+2.6%
Q3 FY2023CQ1 2023Apr 30, 20230M+1.0%
Q2 FY2023CQ4 2022Jan 31, 20230M-15.7%
Q1 FY2023CQ3 2022Oct 31, 20220M+1.8%
Q4 FY2022CQ2 2022Jul 31, 20220M+227.1%
Q3 FY2022CQ1 2022Apr 30, 20220M–
Q2 FY2022CQ4 2021Jan 31, 20220M–
Q1 FY2022CQ3 2021Oct 31, 20210M–
Q3 FY2021CQ1 2021Apr 30, 20210M–

More BriaCell Therapeutics figures

See a number that looks wrong?